Bicocca Open Archive

Logo unimib boa
SORIA, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.033
EU - Europa 1.926
AS - Asia 1.167
SA - Sud America 138
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 4
Totale 6.286
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.983
IT - Italia 404
SG - Singapore 377
DE - Germania 331
RU - Federazione Russa 327
HK - Hong Kong 285
SE - Svezia 253
IE - Irlanda 203
VN - Vietnam 196
CN - Cina 164
BR - Brasile 108
FR - Francia 104
GB - Regno Unito 72
UA - Ucraina 61
CA - Canada 43
ID - Indonesia 43
AT - Austria 40
IN - India 38
DK - Danimarca 30
FI - Finlandia 28
NL - Olanda 21
TR - Turchia 20
CO - Colombia 14
BE - Belgio 13
KR - Corea 11
PL - Polonia 8
AR - Argentina 7
CZ - Repubblica Ceca 7
IR - Iran 7
CL - Cile 4
ES - Italia 4
EU - Europa 4
GR - Grecia 4
JP - Giappone 4
BG - Bulgaria 3
CH - Svizzera 3
IQ - Iraq 3
KE - Kenya 3
MX - Messico 3
PH - Filippine 3
PK - Pakistan 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
AZ - Azerbaigian 2
EC - Ecuador 2
LT - Lituania 2
NZ - Nuova Zelanda 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BD - Bangladesh 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EE - Estonia 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SN - Senegal 1
UZ - Uzbekistan 1
VE - Venezuela 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.286
Salva come PNG Salva come JPEG
Città #
Ann Arbor 894
Hong Kong 285
Frankfurt am Main 247
Chandler 244
Singapore 235
Fairfield 225
Dublin 200
Wilmington 146
Ashburn 127
New York 122
Woodbridge 111
Houston 107
Seattle 87
Paris 79
Milan 77
Cambridge 70
Princeton 70
Santa Clara 63
Hanoi 62
Jacksonville 48
Ho Chi Minh City 47
Jakarta 43
Altamura 37
Dearborn 36
Moscow 33
Lawrence 32
Vienna 30
Shanghai 26
Guangzhou 19
London 19
Nanjing 19
Pune 19
Los Angeles 18
Andover 17
Fremont 17
Boardman 15
Rome 15
Dong Ket 14
Beijing 13
Ottawa 13
Brussels 12
Helsinki 12
Munich 12
Nuremberg 12
San Diego 12
Seoul 11
Bogotá 10
Council Bluffs 9
Lachine 9
Catania 8
Dallas 8
Falls Church 8
Hefei 8
Shenyang 8
São Paulo 8
Boston 7
Busto Arsizio 7
Changsha 7
Haiphong 7
Hebei 7
Kent 7
Lissone 7
Monza 7
Toronto 7
Florence 6
Hải Dương 6
Nanchang 6
The Dalles 6
Thái Nguyên 6
Vũng Tàu 6
Amsterdam 5
Bresso 5
Brno 5
Brooklyn 5
Da Nang 5
Edmonton 5
Jinan 5
Kiev 5
Palermo 5
Peschiera Borromeo 5
Quận Bình Thạnh 5
Rovereto 5
Turin 5
Washington 5
Bexley 4
Brescia 4
Enterprise 4
Konya 4
Lappeenranta 4
Ningbo 4
Phoenix 4
Polska 4
Stockholm 4
Athens 3
Biên Hòa 3
Carate Brianza 3
Chicago 3
Guarulhos 3
Hangzhou 3
Kocaeli 3
Totale 4.354
Salva come PNG Salva come JPEG
Nome #
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 392
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 254
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 254
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 252
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 237
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 233
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 229
HIV testing: A must for patients with inflammatory bowel disease 226
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 219
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 210
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 204
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 199
High rates of 30-day mortality in patients with cirrhosis and COVID-19 195
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 193
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 189
Unmasking tuberculosis in the era of antiretroviral treatment 185
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 180
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 180
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 175
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 161
Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests 154
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 144
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 139
Beware of biases in observational studies on anti-spike monoclonal antibodies 132
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 132
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 128
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 124
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 111
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 106
Knowledge, Use, and Misuse of Self-Prescribed Doxycycline Postexposure Prophylaxis in a Community-Based Preexposure Prophylaxis Service 96
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 93
Pharmacotherapy of HIV: Focus on Etravirine 85
Imported ciprofloxacin-resistant Neisseria meningitidis 84
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 83
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 79
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 77
Unexpected viral relapses in hepatitis C virus–infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals 77
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 67
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study 62
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 61
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition 59
COVID-19 Infection among Incarcerated Individuals and Prison Staff in Lombardy, Italy, March 2020 to February 2021 57
Reply 24
Reply 18
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 3
Totale 6.562
Salva come PNG Salva come JPEG
Categoria #
all - tutte 25.143
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.143
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202043 0 0 0 0 0 0 0 0 0 0 0 43
2020/20211.042 37 49 70 120 120 90 73 100 93 109 63 118
2021/2022777 89 95 125 80 33 73 8 33 18 59 60 104
2022/20231.042 107 310 106 97 52 151 17 74 63 9 38 18
2023/2024711 26 18 30 24 100 222 126 34 36 19 8 68
2024/20251.980 84 189 128 79 155 92 141 66 154 258 140 494
Totale 6.562